Bliss GVS Pharma IDC Recommends on Open Offer by Anupam Rasayan
Bliss GVS Pharma Limited's Committee of Independent Directors (IDC) has issued recommendations regarding an open offer made by Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited. The offer aims to acquire up to 2,77,26,848 equity shares, representing 26.00% of the expanded voting share capital, at a price of INR 299.00 per share. The total offer size is INR 829,03,27,552.00. The IDC, comprising Mr. Nandkumar Kashinath Chodankar (Chairperson), Ms. Shilpa Vinodkumar Bhatia, Mr. Vijayanarayanan Mahadevan, and Mr. Deepak Rameshchandra Shah, has provided their reasoned recommendations as per SEBI (SAST) Regulations. All IDC members are independent directors, with only the Chairperson holding a nominal 250 equity shares in the target company.
Key Highlights
- Independent Directors Committee reviewed open offer from Anupam Rasayan.
- Offer price set at INR 299.00 per share for 26% stake.
- Total offer value amounts to INR 829.03 Crores.
- IDC members are independent, with minimal shareholding.
- Recommendations are in compliance with SEBI (SAST) Regulations.
Price Impact
More from BLISSGVS